KC Pharmaceuticals Issues Recall For Contaminated Eye Drops

KC Pharmaceuticals Issues Recall For Contaminated Eye Drops...

KC Pharmaceuticals has issued a nationwide recall for several batches of its popular eye drops after tests revealed potential contamination. The announcement, made on April 5, 2026, comes in response to reports of adverse reactions, including eye irritation and blurred vision, from users across the United States.

The recall affects three product lines: KC ClearVision, KC MoisturePlus, and KC Night Relief. The company has urged consumers to immediately stop using the affected products and return them to the point of purchase for a full refund. The contaminated batches were distributed to major retailers, including CVS, Walgreens, and Walmart, between January and March 2026.

KC Pharmaceuticals has not yet disclosed the specific contaminant but stated that it is working closely with the FDA to investigate the issue. The company emphasized that no serious injuries have been reported so far, but advised anyone experiencing severe symptoms to seek medical attention.

The recall has sparked widespread concern among consumers, many of whom rely on these eye drops for daily comfort and vision care. Social media platforms have been flooded with reactions, with users expressing frustration and calling for stricter oversight of over-the-counter medications.

This incident highlights ongoing concerns about the safety of pharmaceutical products in the U.S., particularly those sold without a prescription. It also underscores the importance of rigorous quality control in manufacturing processes. KC Pharmaceuticals has pledged to implement additional safety measures to prevent similar issues in the future.

For more information, consumers can visit the KC Pharmaceuticals website or contact their customer service hotline. The FDA has also set up a dedicated webpage to provide updates on the recall and its investigation.